Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in Children

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 5, 2025

Primary Completion Date

April 20, 2026

Study Completion Date

June 30, 2026

Conditions
Soft Tissue Injuries
Interventions
DRUG

OraVerse

Phentolamine mesylate is a vaso-dilator that was used for treating dermal necrosis and severe hypertension cases since 1952. It is alpha-adrenergic antagonist. Oraverse is supplied in a dose equal to the amount of LA taken in adults and children with weights more than 30 kg. While in children less than 30 kg, it is advised to use only half carpule according the manufacturer's instructions.

Trial Locations (1)

11562

RECRUITING

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER